Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated (Q28186346)

DNA topoisomerases: structure, function, and mechanism

Europe PubMed Central

title

Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated (English)

0 references

author name string

T A H Järvinen

series ordinal

1

0 references

E T Liu

series ordinal

2

0 references

language of work or name

English

0 references

publication date

December 2003

0 references

published in

Cytopathology

0 references

volume

14

0 references

issue

6

0 references

page(s)

309-13

0 references

cites work

1 reference

https://api.crossref.org/works/10.1046/J.0956-5507.2003.00105.X

HER-2/neu and topoisomerase IIalpha in breast cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

HER-2/neu and topoisomerase IIalpha--simultaneous drug targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

HER-2 and TOP2A coamplification in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Amplification and expression of genes from the 17q11 approximately q12 amplicon in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Comparison of Topoisomerase-IIα Gene Status between Primary Breast Cancer and Corresponding Distant Metastatic Sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

Topoisomerase II-alpha (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0956-5507.2003.00105.X

10.1046/J.0956-5507.2003.00105.X

21 January 2018

Identifiers

DOI

0 references

Fatcat ID

release_yef6jmg7mzgn7pc5jxbl35b2bm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yef6jmg7mzgn7pc5jxbl35b2bm